CompletedNCT00735371
Lisdexamfetamine Dimesylate (LDX) for ADHD
This study is completed in the United States. It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.
In United StatesADHDBehavioralFrom 13 Years to 17 Years
Study directory
Back to overviewMental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
TerminatedNCT00771134
Lu AA39959 for depression in bipolarity
This study was terminated in the United States. It is testing Lu AA39959 for depression in bipolarity.
In United StatesBipolarity, DepressionDrugA study involving a medication or substance.From 18 Years to 65 Years
CompletedNCT01239030
Methylphenidate HCl ER Capsules for ADHD
This study is completed in the United States. It is testing Methylphenidate HCl ER Capsules for ADHD.
In United StatesADHDDrugFrom 6 Years to 18 Years
TerminatedNCT04663321
MK-1942 When Added to Stable Antidepressant Therapy for treatment-resistant depression
This study was terminated in the United States. It is testing MK-1942 When Added to Stable Antidepressant Therapy for treatment-resistant depression.
In United StatesDepressionDrugFrom 18 Years to 65 Years
CompletedNCT02777931
NFC-1 for ADHD
This study is completed in the United States. It is testing NFC-1 for ADHD.
Remote / onlineADHDDrugFrom 12 Years to 17 Years
CompletedNCT00467428
NS2359 for ADHD
This study is completed in the United States. It is testing NS2359 for ADHD.
In United StatesADHDDrugFrom 18 Years to 55 Years
CompletedNCT00190736
Once-Daily Atomoxetine Hydrochloride for ADHD
This study is completed in the United States. It is testing Once-Daily Atomoxetine Hydrochloride for ADHD.
In United StatesADHDDrugFrom 18 Years to 54 Years
CompletedNCT02970305
Pimavanserin for schizophrenia
This study is completed in the United States, in Canada, in Bulgaria, .... It is testing pimavanserin for schizophrenia.
In United StatesSchizophreniaDrugFrom 18 Years to 55 Years
CompletedNCT00114686
Quetiapine Fumarate (SEROQUEL®) for Bipolarity
This study is completed in the United States. It is testing Quetiapine Fumarate (SEROQUEL®) for Bipolarity.
In United StatesBipolarityDrugFrom 21 Years to 60 Years
TerminatedNCT01467713
Ramelteon Sublingual for Bipolarity
This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for Bipolarity.
In United StatesBipolarityDrugFrom 18 Years to 75 Years
TerminatedNCT01467700
Ramelteon Sublingual for depression
This study was terminated in the United States, in Argentina, in Chile, .... It is testing ramelteon Sublingual for depression.
In United StatesDepression, BipolarityDrugFrom 18 Years to 75 Years
CompletedNCT00481975
Rimonabant on Weight Loss and Frequency of Binge Episodes for Eating disorders
This study is completed in the United States, in France, in Switzerland, .... It is testing rimonabant on Weight Loss and Frequency of Binge Episodes for Eating disorders.
In United StatesEating disordersDrugFrom 18 Years to 70 Years
Public registry coverage is progressing
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.